South African Medical News

Back to Home Page

Print using browser
Novartis discontinue Catafast D 50 mg dispersible tablets 15 (diclofenac)

novartislogo



Dear Healthcare Professional

Novartis Pharmaceuticals wish to inform you that the Catafast D 15 pack is discontinued pending a 9 pack replacement, which is pending production.

The Catafast 9 pack will retain Schedule 2 status.

If you have any further queries, please contact your Novartis representative or the Customer Support Line 0861 929 929.

        * This is a drug - read the leaflet carefully before use.

        * Ask your doctor or pharmacist for further information.

FOR FULL PRESCRIBING INFORMATION REFER TO THE PACKAGE INSERT APPROVED BY THE MEDICINES REGULATORY AUTHORITY.

Novartis apologise for the inconvenience this may cause and thank you for your continued support. 


Applicant: Novartis South Africa (Pty) Ltd, Company Reg. No. 1946/020671/07. 72 Steel Road, Spartan, Kempton Park.

You need to be logged in to see more details. Register Now!


Click here to visit the Novartis website...
Contact: Linda Bisset, Franchise Director, Neuroscience
Telephone: +27 (0) 11 347 6600
E-mail:
Date: Wednesday, May 2, 2018